Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines is a research paper published in Cell (2021). On theSindex it has a DataRank of 0.788. It has been cited 190 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.788
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: F32 AI152296
Burroughs Wellcome Fund
Grant: HHSN272201700036I-75N93020F00001
Bill and Melinda Gates Foundation
Grant: OPP1156262
National Institute of Allergy and Infectious Diseases
Grant: 5T32GM008268-32
Molecular Biophysics Training Program
NIAID NIH HHS
Grant: DP1 AI158186
NIAID NIH HHS
Grant: HHSN272201700059C
National Institute of General Medical Sciences
Grant: R01GM120553
NIGMS NIH HHS
Grant: T32 GM008268
Defense Threat Reduction Agency
Grant: HDTRA1-18-1-0001
NIAID NIH HHS
Grant: T32 AI007151
NIAID NIH HHS
Grant: R01 AI127521
Burroughs Wellcome Fund
Grant: U01 AI149644
NIAID NIH HHS
Grant: U01 AI151698
GlaxoSmithKline
Grant: 63/032,502
Bill and Melinda Gates Foundation
Grant: INV\u2013017592
Office of Research Infrastructure Programs, National Institutes of Health
Grant: P51-OD010425
National Institute of Allergy and Infectious Diseases
Grant: R01-AI127521
Bill and Melinda Gates Foundation
Grant: 017592
NIH HHS
Grant: P51 OD010425
National Institutes of Health
Grant: 1F32AI152296-01A1
Defining viral and immune mechanisms of Dengue virus serotype 2 immune evasion
National Institutes of Health
Grant: 3P51OD010425-53S1
Washington National Primate Research Center
National Institutes of Health
Grant: 5R01GM120553-03
Structural Studies of Coronavirus Fusion Proteins
National Institutes of Health
Grant: 1U01AI149644-01
Respiratory Virus Vaccine and Adjuvant Exploration
National Institutes of Health
Grant: 5DP1AI158186-05
Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics
National Institutes of Health
Grant: 5T32AI007151-42
Infectious Disease Pathogenesis Research Training Program
National Institutes of Health
Grant: 5R01AI127521-03
Structure, Function and Antigenicity of Coronavirus Spike Proteins
University of Washington
Gilead Sciences
Howard Hughes Medical Institute
North Carolina General Assembly
Pfizer
FWCI
9.73
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies